Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Benzatropine

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44380   clinical trials with a EudraCT protocol, of which   7392   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  Next»
    Study title: Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 41948
    Study title: Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 22243
    Study title: Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 41947
    Study title: Benztropine for acute muscle spasm in the emergency department.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 41945
    Study title: Controlled study of pimozide vs. placebo in Tourette's syndrome.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 22247
    Study title: Controlled study of pimozide vs. placebo in Tourette's syndrome.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 41951
    Study title: Management of drooling in cerebral palsy: three single case studies.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 41946
    Study title: New pharmacological approaches in the treatment of Tourette syndrome.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 22249
    Study title: New pharmacological approaches in the treatment of Tourette syndrome.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 41953
    Study title: Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 41958
    Study title: Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.Applicazioni in Pediatria: Dermatologia
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 22254
    Study title: Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 22245
    Study title: Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 41949
    Study title: Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 22252
    Study title: Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 41956
    Study title: Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 22246
    Study title: Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 41950
    Study title: Reversal of antiparkinsonian drug toxicity by physostigmine: a controlled study.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 22253
    Study title: Reversal of antiparkinsonian drug toxicity by physostigmine: a controlled study.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 41957
    Study title: The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine.
    Active substance: BENZATROPINE
    Study summary document link (including results):
    View full study record
    Document reference: 22251
    1  2  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Feb 12 19:21:00 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA